TMO logo
Thermo Fisher Scientific Inc.
TMO
613.78 (-0.75%) 4.62
Market cap
$226.94(B)
Earnings date
Oct-21-2026
Category
Sector
Health Care
Industry
Life Sciences Tools and Services
Thermo Fisher Scientific Inc. provides life sciences solutions analytical instruments specialty diagnostics and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions Analytical Instruments Specialty Diagnostics and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents instruments and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments consumables software and services for pharmaceutical biotechnology academic government environmental and other research and industrial markets as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits calibrators controls protein detection assays and instruments; immunodiagnostic offerings comprising developing manufacturing and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy asthma and autoimmune diseases; microbiology offerings such as dehydrated and prepared culture media collection and transport systems instrumentation and consumables to detect pathogens in blood diagnostic and rapid direct specimen tests quality-control products and associated products; transplant diagnostics products including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products research and safety market channel and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham Massachusetts.
EV: $271.53(B)
Total Equity: $52.81(B)
Debt/Equity: 0.81
Dividend/share: $1.8
Div. yield: 0.29%
P/E: 32.95
Forward P/E: 24.43
P/FCF: 31.01
P/S: 4.95
P/B: 4.31
EPS: $18.6
EPS (fwd): $25.1
FCF/share: $19.8
Revenue/share: $123.9
Book value/share: $142.5
ROIC: 7.7%
ROA: 6.5%
ROE: 13.1%
Margins: Gross | Op. | Net
41.0% | 18.4% | 15.0%
0.0%of Portfolio
My holdings
Day change
Total change
PEvaluation
35%
$399
Valuation summary
Min
Max
Average
Median
Valuation comparison
Current price$614
Quality checklist score
5/8
Based on your selected metrics.
5Y Shares Out Change < 0% Debt/Equity < 1 Current Ratio > 1 Net Margin > 10% Est. EPS Growth > 5%
ROIC > 10% Quick Ratio > 1 Past Net Income CAGR > 0%

TTM Financials

Income (TTM)

RevenueGrossNet
Revenue$46.34(B)
Gross profit$18.99(B)
EBITDA$11.74(B)
Net income$6.97(B)
Gross margin41.0%
Operating margin18.4%
Net margin15.0%
Shares outstanding369.75(M)

Balance sheet

Cash & ST inv.Other ST assetsLong term assetsCurrent liabilitiesLong term debtOther LT liabilitiesEquity
Total assets$113.17(B)
Current assets$23.36(B)
Total liabilities$60.37(B)
Current liabilities$15.07(B)
Cash & Short-term inv.$4.06(B)
Long-term debt$38.92(B)
Total intangibles$73.44(B)
PP&E$10.76(B)

Cash flow (TTM)

CFOCFICFF
FCF$7.32(B)
CapEx$-1.70(B)
Dividends paid$-662.00(M)
Stock issued$0
Stock repurchased$-5.00(B)
Stock-based comp.$319.00(M)
Debt issued$11.64(B)
Debt repaid$-3.68(B)

Per share data (TTM)

Price
Price
$614
Income
Revenue
$1245.0x|20.2%
Gross profit
$51.411.9x|8.4%
Earnings (EPS)
$18.632.9x|3.0%
Cash flow
FCF
$19.831.0x|3.2%
Stock-based comp.
$0.86711.4x|0.1%
CapEx
$4.58133.9x|0.7%
Dividend
$1.80341.0x|0.3%
Balance sheet
Total assets
$3062.0x|49.9%
Total liabilities
$1633.8x|26.6%
Book value
$1424.3x|23.2%
Cash & ST inv.
$11.055.8x|1.8%
Debt
$1055.8x|17.1%
Forward earnings
EPS FY+1
$25.124.4x|4.1%
EPS FY+2
$27.522.3x|4.5%
EPS FY+3
$30.420.2x|4.9%
EPS FY+4
$34.218.0x|5.6%
EPS FY+5
$37.816.3x|6.2%
Forward FCF
FCF FY+1
$19.132.1x|3.1%
FCF FY+2
$24.824.8x|4.0%
FCF FY+3
$26.423.2x|4.3%
FCF FY+4
$28.521.6x|4.6%
FCF FY+5
$31.419.6x|5.1%

Summary

TMO Valuation & Price Targets

Favorite Valuation Methods

PEvaluation
Analyst targets
DCF (2-stage)

More Valuation Methods

DCF (simple)
DCF (exit mult.)
DDM
EPS growth
Revenue growth
Peter Lynch FV
Graham No.

PEvaluation

CURRENT PRICE
$614
35% Overvalued
BEAR
BASE
BULL
Fair P/E
Margin of safety
EPS
Market Model
ROICRevenue growthFCF MarginShares outstan...Debt/EquityDebt/EBITDA
Economic moat: Medium

EPS Estimates

LowAvgHigh#
FY+125.025.125.326
FY+226.527.529.127
FY+328.830.431.717
FY+433.134.235.05
FY+536.937.839.53

Analyst Price Targets

CURRENT PRICE
$614
5% Undervalued
BEAR
BASE
BULL

Analyst Recommendations

Strong Buy3
Buy19
Hold5
Sell0
Strong Sell1

2-stage DCF

First Stage Duration: 5 Years
Starting Free Cash Flow
First Stage Growth Rate
Low
Mid
High
Terminal Growth Rate
Low
Mid
High
Discount Rate

Discounted Cash Flow

Forecast years: 5 Years
Terminal Growth Rate
Low
Mid
High
Discount Rate
Free cash flow estimates:
Y+1 est.
Y+2 est.
0.00%
Y+3 est.
0.00%
Y+4 est.
0.00%
Y+5 est.
0.00%

Discounted Cash Flow (exit mult.)

Forecast years: 5 Years
Exit FCF Multiple
Low
Mid
High
Discount Rate
Free cash flow estimates:
Y+1 est.
Y+2 est.
0.00%
Y+3 est.
0.00%
Y+4 est.
0.00%
Y+5 est.
0.00%

Dividend Discount Model

Annual Dividend
First Stage Length (Years): 0 Years
First Stage Growth Rate
Low
Mid
High
Final Growth Rate
Low
Mid
High
Discount Rate

EPS Growth

Forecast years: 5 Years
Starting EPS
EPS Growth Rate
Low
Mid
High
Final P/E
Low
Mid
High
Discount Rate

Revenue Growth Valuation

Forecast Years: 10 Years
Base Revenue
Revenue Growth Rate
Low
Mid
High
Final Net Margin
Low
Mid
High
Final P/E Ratio
Low
Mid
High
Discount Rate

Peter Lynch Fair Value

Earnings Per Share
Growth Rate
Low
Mid
High

Graham Formula

Earnings Per Share
EPS Growth (7-10 years)
Low
Mid
High
Government Bond Rate

Growth Estimates

Revenue

CAGR4.8%
TTMFY+1FY+2FY+3FY+4FY+5
TTM
$46.34(B)
FY+1
25
3%
$47.86(B)
FY+2
25
5%
$50.32(B)
FY+3
17
6%
$53.45(B)
FY+4
4
5%
$56.25(B)
FY+5
2
4%
$58.48(B)

Net Income

CAGR13.3%
TTMFY+1FY+2FY+3FY+4FY+5
TTM
$6.97(B)
FY+1
22
34%
$9.33(B)
FY+2
22
8%
$10.12(B)
FY+3
15
9%
$11.01(B)
FY+4
4
10%
$12.17(B)
FY+5
2
7%
$12.99(B)

EPS

CAGR15.2%
TTMFY+1FY+2FY+3FY+4FY+5
TTM
$18.63
FY+1
26
35%
$25.12
FY+2
27
10%
$27.51
FY+3
17
10%
$30.36
FY+4
5
13%
$34.16
FY+5
3
11%
$37.77

FCF per share

CAGR9.7%
TTMFY+1FY+2FY+3FY+4FY+5
TTM
$19.79
FY+1
5
3%
$19.12
FY+2
6
30%
$24.78
FY+3
4
7%
$26.43
FY+4
3
8%
$28.46
FY+5
2
10%
$31.38

Historical Financials (in USD)

Income(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.010.0(B)20.0(B)30.0(B)40.0(B)
Revenue Operating Income Net IncomeCOGSGross ProfitTotal OpEx.R&DSG&AInterest ExpenseInterest IncomeOther Non-operating IncomePre-tax incomeIncome tax
Cash flow(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.02.0(B)4.0(B)6.0(B)
Stock-based Comp. FCFCFONet IncomeD&AChange in Working CapitalCFFStock IssuedStock RepurchasedDebt IssuedDebt RepaidDividend PaidCFIAcquisitionsDivestituresCapital Expenditures
Balance sheet(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.020.0(B)40.0(B)60.0(B)80.0(B)100.0(B)
Total Assets Total LiabilitiesCurrent assetsCash and EquivalentsShort-term investmentsInventoriesReceivablesNon-current assetsNet PP&EIntangible AssetsGoodwillCurrent liabilitiesShort-Term DebtAccounts payableNon-current liabilitiesLong-Term DebtTotal Equity
Per share data(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.05.010.015.020.0
EPS (Basic) FCF/Share Dividend/ShareEPS (Diluted)Book value/ShareCash & ST inv./ShareDebt/Share
Ratios(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.010.020.030.0
P/E P/S EV/EarningsP/FCFP/BDebt/EquityPayout ratio
Margins(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0%10%20%30%40%50%
Net Income Margin Operating Margin Gross MarginEBITDA Margin
Returns(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0%2%4%6%8%10%12%14%
ROIC ROAROCEROE
Shares outstanding(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.0100.0(M)200.0(M)300.0(M)
Shares (Basic)Shares (Diluted)
Market Cap.(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.050.0(B)100.0(B)150.0(B)200.0(B)
Market Cap.

TMO vs Peers

Similar Companies

Ownership

Major holders

*Excludes indirect insider ownership

Insiders: 0.14%
Institutions: 93.61%
Other: 6.25%

Institutional ownership

8.36% Blackrock Inc.6.57% Vanguard Capital Manag...4.55% State Street Corporati...2.94% Morgan Stanley2.91% FMR, LLC2.27% Geode Capital Manageme...1.84% Franklin Resources, In...1.84% JPMORGAN CHASE & CO1.80% Capital World Investor...1.71% Price (T.Rowe) Associa...58.82% Others

Trading Summary

In the past year, insiders have sold a net of $126.19(M).

Total insider buys: $0.00
Total insider sells: $126.19(M)

In the past year, Congress members have sold a net of $105004.

Total congressional buys (avg): $48502
Total congressional sells (avg): $153505

Based on the reported ranges: buys $17003–$80000, sells $52010–$255000.

Insider transactions

$0.002026-10$0.00
$0.002026-09$0.00
$23.75(M)2026-08$0.00
$2260002026-07$0.00
$0.002026-06$0.00
$0.002026-05$0.00
$1850642026-04$0.00
$7.94(M)2026-03$0.00
$2164802026-02$0.00
$0.002026-01$0.00
$56.70(M)2025-12$0.00
$17.38(M)2025-11$0.00
$14.14(M)2025-10$0.00
DateSharesTotal ($)Price ($)NameTitle
Grant2026-08-0727585,148309.6CASPER MARC NChief Executive Officer
Grant2026-08-07420130,045309.6HOLMES JOSEPH R.Officer
Sell2026-08-074,8832,862,002586.1CASPER MARC NChief Executive Officer
Sell2026-08-07420245,620584.8HOLMES JOSEPH R.Officer
Grant2026-08-0610,0003,096,300309.6CASPER MARC NChief Executive Officer
Grant2026-08-065,8501,811,336309.6BRITT LISA POfficer
Sell2026-08-0615,0008,616,967574.5CASPER MARC NChief Executive Officer
Sell2026-08-065,8503,393,000580.0BRITT LISA POfficer
Grant2026-08-0510,0003,096,300309.6CASPER MARC NChief Executive Officer
Sell2026-08-0515,0008,628,434575.2CASPER MARC NChief Executive Officer
Sell2026-07-27400226,000565.0PETTITI GIANLUCAPresident
Grant2026-05-2049900.0JOHNSON JENNIFER MDirector
Grant2026-05-2049900.0HARRIS C. MARTIN M.D.Director
Grant2026-05-2049900.0SPERLING SCOTT MDirector
Grant2026-05-2049900.0CHANDY RUBY RDirector
Grant2026-05-2049900.0CHAI NELSON JDirector
Grant2026-05-2049900.0WEISLER DION JDirector
Grant2026-05-2049900.0KEITH R ALEXANDRADirector
Grant2026-05-2049900.0LYNCH KAREN S.Director
Grant2026-05-2049900.0JACKS TYLERDirector
Grant2026-05-2049900.0SPAR DEBORA LDirector
Sell2026-04-27400185,064462.7PETTITI GIANLUCAPresident
Sell2026-03-111,607802,536499.4SHAFER MICHAEL DOfficer
Grant2026-03-054,0001,238,520309.6CASPER MARC NChief Executive Officer
Sell2026-03-054,0002,059,261514.8CASPER MARC NChief Executive Officer
Grant2026-03-0410,0003,096,300309.6CASPER MARC NChief Executive Officer
Sell2026-03-0410,0005,077,489507.7CASPER MARC NChief Executive Officer
Grant2026-02-2597800.0SHROPSHIRE THOMAS B JR.General Counsel
Grant2026-02-251,63800.0LOWERY FREDERICK M.Officer
Grant2026-02-255,77200.0PETTITI GIANLUCAOfficer
Grant2026-02-2577000.0HOLMES JOSEPH R.Officer
Grant2026-02-254,69800.0SHAFER MICHAEL DOfficer
Grant2026-02-2514,84800.0CASPER MARC NChief Executive Officer
Grant2026-02-251,53400.0WILLIAMSON STEPHENChief Financial Officer
Grant2026-02-252,04500.0BRITT LISA POfficer
Grant2026-02-252,23100.0LAGARDE MICHELChief Operating Officer
Sell2026-02-09400216,480541.2PETTITI GIANLUCAOfficer
Grant2025-12-104,38600.0SPERLING SCOTT MDirector
Grant2025-12-0440,6834,884,676120.1LAGARDE MICHELChief Operating Officer
Sell2025-12-0422,04612,424,244563.6LAGARDE MICHELChief Operating Officer
Grant2025-12-03104,00010,937,680105.2LAGARDE MICHELChief Operating Officer
Sell2025-12-0362,00036,126,126582.7LAGARDE MICHELChief Operating Officer
Grant2025-12-0213,8253,511,412254.0LOWERY FREDERICK M.Officer
Sell2025-12-0213,8258,154,131589.8LOWERY FREDERICK M.Officer
Grant2025-11-2510,7252,814,110262.4SHAFER MICHAEL DOfficer
Sell2025-11-2510,7256,435,000600.0SHAFER MICHAEL DOfficer
Grant2025-11-1443300.0WILLIAMSON STEPHENChief Financial Officer
Grant2025-11-134,6381,178,006254.0LAGARDE MICHELChief Operating Officer
Sell2025-11-134,6382,756,920594.4LAGARDE MICHELChief Operating Officer
Sell2025-11-121,057622,136588.6BRITT LISA POfficer
Grant2025-11-102,975845,688284.3PETTITI GIANLUCAOfficer
Sell2025-11-102,9751,725,500580.0PETTITI GIANLUCAOfficer
Grant2025-11-078,4752,152,565254.0BRITT LISA POfficer
Sell2025-11-0710,2255,844,850571.6BRITT LISA POfficer
Grant2025-10-2724,3546,185,672254.0CASPER MARC NChief Executive Officer
Sell2025-10-2724,35413,914,104571.3CASPER MARC NChief Executive Officer
Sell2025-10-24400229,660574.1PETTITI GIANLUCAOfficer
Grant2025-09-05400101,596254.0CASPER MARC NChief Executive Officer
Sell2025-09-05400200,201500.5CASPER MARC NChief Executive Officer
Grant2025-08-2938597,786254.0HOLMES JOSEPH R.Officer
Sell2025-08-29385189,662492.6HOLMES JOSEPH R.Officer
Grant2025-08-2210,0002,539,900254.0CASPER MARC NChief Executive Officer
Sell2025-08-2210,0005,009,586501.0CASPER MARC NChief Executive Officer
Grant2025-08-20496125,979254.0CASPER MARC NChief Executive Officer
Sell2025-08-20496248,046500.1CASPER MARC NChief Executive Officer

Congressional trading

$0.002026-10$0.00
$0.002026-09$0.00
$0.002026-08$0.00
$0.002026-07$0.00
$0.002026-06$0.00
$0.002026-05$0.00
$0.002026-04$0.00
$0.002026-03$0.00
$0.002026-02$0.00
$645032026-01$0.00
$0.002025-12$0.00
$0.002025-11$32501
$80012025-10$0.00
DatePoliticianPartyChamberAmount ($)
Sell2026-01-29Ro KhannaDHouse$15,001 - $50,000
Sell2026-01-22Ro KhannaDHouse$1,001 - $15,000
Sell2026-01-22Ro KhannaDHouse$1,001 - $15,000
Sell2026-01-12Ro KhannaDHouse$1,001 - $15,000
Sell2026-01-12Ro KhannaDHouse$1,001 - $15,000
Buy2025-11-07Ro KhannaDHouse$15,001 - $50,000
Sell2025-10-30Lisa C. McClainRHouse$1,001 - $15,000
Buy2025-09-29Ro KhannaDHouse$1,001 - $15,000
Buy2025-09-12Ro KhannaDHouse$1,001 - $15,000
Sell2025-08-19Kelly Louise MorrisonDHouse$15,001 - $50,000
Sell2025-08-19Kelly Louise MorrisonDHouse$1,001 - $15,000
Sell2025-08-19Kelly Louise MorrisonDHouse$15,001 - $50,000
Sell2025-08-19Kelly Louise MorrisonDHouse$1,001 - $15,000

Tools

Dividend Income

Investment Amount
Dividend Yield
What is the Dividend Income Calculator?

The Dividend Income Calculator helps you estimate the yearly, quarterly, monthly, and daily income of your investments.

How to Use This Calculator?

Enter the dividend yield and the invested amount. Optionally, preload stock data to automatically fetch the dividend yield.

Required Investment

Dividend Yield
Desired Yearly Payout
Desired Quarterly Payout
Desired Monthly Payout
What is the Required Investment Calculator?

The Required Investment Calculator helps you determine the amount of money you need to invest in a stock to achieve a desired dividend.

How to Use This Calculator?

Enter the dividend yield and your desired dividend income. Optionally, preload stock data to automatically fetch the dividend yield.

Future Dividend Yield

Base Dividend
Current Price
Number of Years
Dividend Growth Rate
What is the Future Yield Calculator?

The Future Yield Calculator helps you estimate the future dividend yield of a stock based on its current dividend, price, and expected dividend growth rate.

How to Use This Calculator?

Enter the base dividend, current price, number of years, and dividend growth rate. Optionally, preload stock data to automatically fetch the dividend and price. The calculator will display the current yield and the projected future yield.

Future Dividend Income

Base Dividend
Number of Years
Dividend Growth Rate
What is the Future Dividend Income Calculator?

The Future Dividend Income Calculator helps you estimate the future dividend income from your investments based on the current dividend yield and expected growth rate.

How to Use This Calculator?

Enter the current dividend yield, expected growth rate, and investment duration. Optionally, preload stock data to automatically fetch the dividend yield.